Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial.

导出原文传递

翻译打印收藏纠错

作者： Au HJ ^[1] ; Karapetis CS ; O'Callaghan CJ ; Tu D ; Moore MJ ; Zalcberg JR ; Kennecke H ; Shapiro JD ; Koski S ; Pavlakis N ; Charpentier D ; Wyld D ; Jefford M ; Knight GJ ; Magoski NM ; Brundage MD ; Jonker DJ

作者单位： Cross Cancer Institute, Edmonton, Alberta, Canada. heathera@cancerboard.ab.ca ^[1]

关键词 IMC C225 week K-ras Oncogenes

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Clinical Oncology

2009年27卷11期

1822-1828页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial.

Journal of Clinical Oncology

相似文献

Journal of Clinical Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial.

Journal of Clinical Oncology

相似文献

Journal of Clinical Oncology

相关期刊

检索历史清除